{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:50:39Z","timestamp":1760853039186},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1986,9,1]],"date-time":"1986-09-01T00:00:00Z","timestamp":525916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1986,9]]},"DOI":"10.1007\/bf00542420","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T04:41:33Z","timestamp":1100839293000},"page":"591-596","source":"Crossref","is-referenced-by-count":17,"title":["Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease"],"prefix":"10.1007","volume":"30","author":[{"given":"M.","family":"L\u00e1zn\u00ed\u010dek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E. O.","family":"Senius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00542420_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00567126","volume":"8","author":"M Affrime","year":"1975","unstructured":"Affrime M, Reidenberg MM (1975) The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol 8: 267\u2013269","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00542420_CR2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0773.1973.tb01488.x","volume":"32","author":"F Andreasen","year":"1973","unstructured":"Andreasen F (1973) Protein binding of drugs in plasma from patients with acute renal failure. Acta Pharmacol Toxicol (Copenh) 32: 417\u2013429","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF00542420_CR3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0773.1974.tb03525.x","volume":"34","author":"F Andreasen","year":"1974","unstructured":"Andreasen F (1974) The effect of dialysis on the protein binding of drugs in the plasma of patients with acute renal failure. Acta Pharmacol Toxicol (Copenh) 34: 284\u2013294","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF00542420_CR4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/cpt1976204464","volume":"20","author":"O Borg\u00e5","year":"1976","unstructured":"Borg\u00e5 O, Odar-Cederl\u00f6f I, Ringberger V-A, Norlin A (1976) Protein binding of salicylate in uremic and normal plasma. Clin Pharmacol Ther 20: 464\u2013475","journal-title":"Clin Pharmacol Ther"},{"key":"BF00542420_CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cpt1974163part1424","volume":"16","author":"M Ehrnebo","year":"1974","unstructured":"Ehrnebo M, Agurell S, Bor\u00e9us LO, Gordon E, L\u00f6nroth U (1974) Pentazocine binding to blood cells and plasma proteins. Clin Pharmacol Ther 16: 424\u2013429","journal-title":"Clin Pharmacol Ther"},{"key":"BF00542420_CR6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/clpt.1980.87","volume":"27","author":"S Erill","year":"1980","unstructured":"Erill S, Calvo R, Carlos R (1980) Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther 27: 612\u2013618","journal-title":"Clin Pharmacol Ther"},{"key":"BF00542420_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0006-2952(81)90151-9","volume":"30","author":"KJ Fehske","year":"1981","unstructured":"Fehske KJ, M\u00fcller WE, Wollert U (1981) The location of drug binding sites in human serum albumin. Biochem Pharmacol 30: 687\u2013692","journal-title":"Biochem Pharmacol"},{"key":"BF00542420_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(79)90343-X","volume":"2","author":"H Hakkarainen","year":"1979","unstructured":"Hakkarainen H, Vapaatalo H, Gothoni G, Parantainen J (1979) Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet 2: 326\u2013328","journal-title":"Lancet"},{"key":"BF00542420_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0003-2697(75)90193-1","volume":"63","author":"DL Hunston","year":"1975","unstructured":"Hunston DL (1975) Two techniques for evaluating small molecule \u2014 macromolecule binding in complex system. Anal Biochem 63: 99\u2013109","journal-title":"Anal Biochem"},{"key":"BF00542420_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/03009747209103003","volume":"1","author":"A Kajander","year":"1972","unstructured":"Kajander A, Laine V, Gothoni G (1972) Effect of tolfenamic acid in rheumatoid arthritis. Scand J Rheumatol 1: 91\u201393","journal-title":"Scand J Rheumatol"},{"key":"BF00542420_CR11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/03009747609165455","volume":"5","author":"A Kajander","year":"1976","unstructured":"Kajander A, Martio J, Mutru O, Gothoni G (1976) Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases. Scand J Rheumatol 5: 158\u2013160","journal-title":"Scand J Rheumatol"},{"key":"BF00542420_CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0090-6980(79)90033-9","volume":"18","author":"A Kauppila","year":"1979","unstructured":"Kauppila A, Puolakka J, Ylikorkala O (1979) Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 18: 655\u2013661","journal-title":"Prostaglandins"},{"key":"BF00542420_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0028-2243(77)90047-8","volume":"7","author":"A Kauppila","year":"1977","unstructured":"Kauppila A, Ylikorkala O (1977) Indomethacin and tolfenamic acid in primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol 7: 59\u201364","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"BF00542420_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF03189629","volume":"7","author":"RG Khalifah","year":"1982","unstructured":"Khalifah RG, Hignite CE, Pentik\u00e4inen PJ, Penttil\u00e4 A, Neuvonen PJ (1982) Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates. Eur J Drug Metabol Pharmacokinet 7: 269\u2013276","journal-title":"Eur J Drug Metabol Pharmacokinet"},{"key":"BF00542420_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/03009747609165450","volume":"5","author":"I-B Lind\u00e9n","year":"1976","unstructured":"Lind\u00e9n I-B, Parantainen J, Vapaatalo H (1976) Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro. Scand J Rheumatol 5: 129\u2013132","journal-title":"Scand J Rheumatol"},{"key":"BF00542420_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00544587","volume":"19","author":"PJ Pentik\u00e4inen","year":"1981","unstructured":"Pentik\u00e4inen PJ, Neuvonen PJ, Backman C (1981) Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. Eur J Clin Pharmacol 19: 359\u2013365","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00542420_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03189628","volume":"7","author":"PJ Pentik\u00e4inen","year":"1982","unstructured":"Pentik\u00e4inen PJ, Penttil\u00e4 A, Neuvonen PJ, Khalifah RG, Hignite CE (1982) Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites. Eur J Drug Metab Pharmacokinet 7: 259\u2013267","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"BF00542420_CR18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00606415","volume":"11","author":"M Per\u00e9z-Mateo","year":"1977","unstructured":"Per\u00e9z-Mateo M, Erill S (1977) Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency. Eur J Clin Pharmacol 11: 225\u2013231","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00542420_CR19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2165\/00003088-198005030-00004","volume":"5","author":"KM Piafsky","year":"1980","unstructured":"Piafsky KM (1980) Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 5: 246\u2013262","journal-title":"Clin Pharmacokinet"},{"key":"BF00542420_CR20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0025-7125(16)32106-X","volume":"58","author":"MM Reidenberg","year":"1974","unstructured":"Reidenberg MM (1974) Effect of disease states on plasma protein binding of drugs. Med Clin North Am 58: 1103\u20131109","journal-title":"Med Clin North Am"},{"key":"BF00542420_CR21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0002-9343(77)90398-9","volume":"62","author":"MM Reidenberg","year":"1977","unstructured":"Reidenberg MM (1977) The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med 62: 466\u2013470","journal-title":"Am J Med"},{"key":"BF00542420_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/03009742.1979.12088620","volume":"Suppl 24","author":"V Rejholec","year":"1979","unstructured":"Rejholec V, Vapaatalo H, Tokola O, Gothoni G (1979a) A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol [Suppl 24]: 13\u201316","journal-title":"Scand J Rheumatol"},{"key":"BF00542420_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/03009742.1979.12088619","volume":"Suppl 24","author":"V Rejholec","year":"1979","unstructured":"Rejholec V, Vapaatalo H, Tokola O, Gothoni G (1979b) Tolfenamic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol [Suppl 24]: 9\u201312","journal-title":"Scand J Rheumatol"},{"key":"BF00542420_CR24","first-page":"278","volume":"107","author":"RC Reynolds","year":"1960","unstructured":"Reynolds RC, Cluff LE (1960) Interaction of serum and sodium salicylate: changes during acute infection and its influence on pharmacological activity. Bull Johns Hopkins Hosp 107: 278\u2013290","journal-title":"Bull Johns Hopkins Hosp"},{"key":"BF00542420_CR25","first-page":"175","volume-title":"Handbook of experimental pharmacology 28","author":"W Settle","year":"1971","unstructured":"Settle W, Hegeman S, Featherstone RM (1971) The nature of drug-protein interaction. In: Handbook of experimental pharmacology 28, I: Brodie BB, Gillette JR (eds) Concepts in biochemical pharmacology. Springer, Berlin Heidelberg New York, pp 175\u2013186"},{"key":"BF00542420_CR26","first-page":"767","volume":"16","author":"I Sj\u00f6holm","year":"1979","unstructured":"Sj\u00f6holm I, Ekman B, Kober A, Ljungstedt-P\u00e5hlman I, Seiving B, Sj\u00f6din T (1979) Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol Pharmacol 16: 767\u2013777","journal-title":"Mol Pharmacol"},{"key":"BF00542420_CR27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0006-2952(76)90370-1","volume":"25","author":"I Sj\u00f6holm","year":"1976","unstructured":"Sj\u00f6holm I, Kober A, Odar-Cederl\u00f6f I, Borg\u00e5 O (1976) Protein binding of drugs in uremic and normal serums: The role of endogenous binding inhibitors. Biochem Pharmacol 25: 1205\u20131213","journal-title":"Biochem Pharmacol"},{"key":"BF00542420_CR28","first-page":"824","volume":"11","author":"G Sudlow","year":"1975","unstructured":"Sudlow G, Birkett DJ, Wade DN (1975) The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11: 824\u2013832","journal-title":"Mol Pharmacol"},{"key":"BF00542420_CR29","first-page":"1052","volume":"12","author":"G Sudlow","year":"1976","unstructured":"Sudlow G, Birkett DJ, Wade DN (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052\u20131061","journal-title":"Mol Pharmacol"},{"key":"BF00542420_CR30","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/0006-2952(82)90597-4","volume":"31","author":"S Urien","year":"1982","unstructured":"Urien S, Albengres E, Zini R, Tillement J-P (1982) Evidence for binding of certain acidic drugs to \u03b11-acid glycoprotein. Biochem Pharmacol 31: 3687\u20133689","journal-title":"Biochem Pharmacol"},{"key":"BF00542420_CR31","first-page":"287","volume-title":"Prostaglandins and vascular headache; action of tolfenamic acid, a new anti-inflammatory analgetic, on migraine","author":"H Vapaatalo","year":"1977","unstructured":"Vapaatalo H, Parantainen J, Lind\u00e9n I-B, Hakkarainen H (1977) Prostaglandins and vascular headache; action of tolfenamic acid, a new anti-inflammatory analgetic, on migraine. Proceedings of the joint meeting of the Italian and Scandinavian Migraine Societies. \u201cHeadache: New Vistas\u201d. Biomedical Press, Florence, pp 287\u2013300"},{"key":"BF00542420_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003088-198207010-00005","volume":"7","author":"S Wanwimolruk","year":"1982","unstructured":"Wanwimolruk S, Birkett DJ, Brooks PM (1982) Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clin Pharmacokinet 7: 85\u201392","journal-title":"Clin Pharmacokinet"},{"key":"BF00542420_CR33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pa.20.040180.002133","volume":"20","author":"RL Williams","year":"1980","unstructured":"Williams RL, Benet LZ (1980) Drug pharmacokinetics in cardiac and hepatic disease. Annu Rev Pharmacol Toxicol 20: 389\u2013413","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF00542420_CR34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00561662","volume":"9","author":"WD Wosilait","year":"1976","unstructured":"Wosilait WD (1976) Theoretical analysis of the binding of salicylate by human serum albumin: The relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285\u2013290","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542420\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T05:39:07Z","timestamp":1585978747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1986,9]]}},"alternative-id":["BF00542420"],"URL":"https:\/\/doi.org\/10.1007\/bf00542420","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,9]]}}}